Authors: Jackson, PF Tays, KL Maclin, KM Ko, YS Li, WX Vitharana, D Tsukamoto, T Stoermer, D Lu, XCM Wozniak, K Slusher, BS

Citation: Pf. Jackson et al., Design and pharmacological activity of phosphinic acid based NAALADase inhibitors, J MED CHEM, 44(24), 2001, pp. 4170-4175

Authors: Thomas, AG Liu, WL Olkowski, JL Tang, ZC Lin, Q Lu, XCM Slusher, BS

Citation: Ag. Thomas et al., Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta, EUR J PHARM, 430(1), 2001, pp. 33-40

Authors: Ferry, AT Lu, XCM Price, JL

Citation: At. Ferry et al., Effects of excitotoxic lesions in the ventral striatopallidal-thalamocortical pathway on odor reversal learning: inability to extinguish an incorrectresponse, EXP BRAIN R, 131(3), 2000, pp. 320-335

Authors: Lu, XCM Tang, ZC Liu, WL Lin, Q Slusher, BS

Citation: Xcm. Lu et al., N-acetylaspartylglutamate protects against transient focal cerebral ischemia in rats, EUR J PHARM, 408(3), 2000, pp. 233-239

Authors: Slusher, BS Vornov, JJ Thomas, AG Hurn, PD Harukuni, I Bhardwaj, A Traystman, RJ Robinson, MB Britton, P Lu, XCM Tortella, FC Wozniak, KM Yudkoff, M Potter, BM Jackson, PF

Citation: Bs. Slusher et al., Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury, NAT MED, 5(12), 1999, pp. 1396-1402

Authors: Tortella, FC Britton, P Williams, A Lu, XCM Newman, AH

Citation: Fc. Tortella et al., Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist, J PHARM EXP, 291(1), 1999, pp. 399-408